Hypertension secondary to multiple malignant paragangliomas;Ipertensione secondaria a paragangliomi maligni multipli

Giornale Italiano di Cardiologia

Volumn 26, Issue 5, 1996, Pages 891-897

  Mazza, Alberto ^a,b   Della Rocca, Foscarina ^a   Mormino, Paolo ^a   Pessina, Achille C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Dip di Medicina Clinica   (Italy)

Author keywords

Hypertension; Paraganglioma

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; NORADRENALIN; PROPRANOLOL;

ADULT; ARTICLE; CASE REPORT; HUMAN; HYPERTENSION; MALE; NORADRENALIN RELEASE; PARAGANGLIOMA;

ADULT; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; NEOPLASMS, MULTIPLE PRIMARY; NOREPINEPHRINE; PARAGANGLIOMA, EXTRA-ADRENAL; RADIOTHERAPY DOSAGE; RETROPERITONEAL NEOPLASMS; TIME FACTORS;

EID: 2442557164     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Manger WM, Gifford RW: Hypertension secondary to pheocromocytoma. Bull NY Acad Med 1982; 58: 139-157.
2. Bravo EL, Gifford RW: Pheocromocytoma: diagnosis, localisation and management. N Engl J Med 1984; 311: 1298-1303.
3. Shapiro B, Fig LM, Gross MD, Hhafagi F: Radiochemical diagnosis of adrenal disease. Crit Rev Clin Lab Sci 1989; 27: 265-298.
4. Shapiro B, Fig LM: Management of pheocromocytoma. Endocrinol Metab Clin North Am 1989; 18: 443-481.
5. Glenner GG, Grimely PM: Tumors of adrenal paraganglion system (including chemoreceptor). In: Atlas Of Tumor Pathology. Whashington. Armed Force Institute of Pathology; 1974; 2: 1-90.
6. Pearse AGE, Polak JM, Rost FWD: Demonstration of the neurocrest origin of type I (APUD) cells in the avian carotid body to using a cytochemical marker system. Histochemistry 1973; 34: 191.
7. Schuppert F, Scheumann GF, Schöber C et al: Therapy of a malignant sympathetic paraganglioma of the organ of Zuckerkandl, a case report. Klin Wochenschr 1991; 69: 937-942.
8. Hasegawa G, Ikarashi T, Ohnishi Y: Malignant paraganglioma of the organ of Zuckerkandl. Initially diagnosed as renal cell carcinoma by biopsy of a right humeral fracture lesion. Acta Pathol Jpn 1989; 39: 274-280.
9. Biller HF, Lawson W, Som P, Rosenfeld R: Glomus vagale tumors. Ann Otol Rhinol Laryngol 1989; 98: 21-26.
10. Smith O, Youngs R, Snell D, Van Nostrand P: Paraganglioma of the larynx. J Otolaryngol 1988; 17: 293-301.
11. Okuno H, Kihara Y, Arai Y: Primary paraganglioma of the urinary bladder: a report of two cases. Hinyokika Kiyo 1990; 36: 691-696.
12. Chevinsky AH, Minton JP, Falko JM: Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type II. Arch Surg 1990; 125: 935-938.
13. Glowniak JV, Shapito B, Sisson JC et al: Familial extra-adrenal pheochromocytoma: a new syndrome. Arch Intern Med 1985; 145: 257-261.
14. Gautier JF, Schlumberger M, Fonseca E et al: Familial pheochromocytoma and Von Hippel-Lindau disease. Presse Med 1990; 19: 1494-1496.
15. Carney JA, Sizemore GW, Sheps SG: Adrenal medullary disease in multiple endocrine neoplasia, type 2. Am J Clin Pathol 1976; 66: 279-290.
16. Kliewer KE, Wen DR, Concilia PA, Cochran AJ: Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques. Hum Pathol 1989; 20: 29-39.
17. Kliewer KE, Cochran AJ: A review of the histology, ultrastructure, immuno- histology, and molecular biology of extra-adrenal paragangliomas. Arch Pathol Lab Med 1989; 113: 1209-1218.
18. Rossi GP, Zanin L, Pessina AC: Misumzione in HPLC delle catecolamine plasmatiche: ottimizzazione della procedura di estrazione e delle condizioni cromatografiche. Giorn It Chim Clin 1989; 14: 123-128.
19. Van Eps RGS, Van den Meiracker AH, Boomsma F, Man in't Veld AJ, Schalekamp M: Diurnal variation of blood pressure in patients with catecholamine-producing tumors. Am J Hypertens 1994; 7: 492-497.
20. Gallen IW,Taylor RS, Salzmann MB, Tooke JE: Twenty-four hour ambulatory blood pressure and heart rate in patient with a predominantly adrenaline secreting phaemochromocytoma. Postgrad Med J 1994; 70: 589-591.
21. Kuvshinoff BW, Nussbaum MS, Richards AI, Bloustein P, McFadden DW: Neuropeptide Y secretion from a malignant extraadrenal retroperitoneal paraganglioma. Cancer 1992; 70: 2350-2353.
22. Florkowski CM, Fairlamb DJ, Freeth MG: Raised dopamine metabolites in a case of malignant paraganglioma. Postgrad Med J 1990; 66: 471-473.
23. Bagnolesi P, Perri G, Cilotti A, Malventi M: Ultrasound and CT in the diagnosis of malignant chemodectoma. Presentation of a case. Radiol Med Torino 1987; 74: 574-577.
24. Hayes WS, Davidson AJ, Grimley PM, Hartman DS: Extraadrenal retroperitoneal paraganglioma: clinical, pathologic, and CT findings. Am J Roentgenol 1990; 155: 1247-1250.
25. Dopman JL, Reing JW: Differentiation of adrenal masses by magnetic resonance imaging. Surgery 1987; 102: 1018.
26. Khafagi FA, Shapiro B, Fischer M, Sisson JC, Hutchinson-R, Beierwaltes WH: Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine. Eur J Nucl Med 1991; 18: 191-198.
27. Sheps SG, Jiang NS, van Heerden JA: Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc 1990; 65: 88-95.
28. Olson JR, Abell MR: Nonfunctional, nonchromaffin paragangliomas of the retroperitoneum. Cancer 1969; 23: 1358-1367.